Vargatef
CAS: 1160294-26-7
Ref. 3D-KWB29426
25mg | 136,00 € | ||
50mg | 172,00 € | ||
100mg | 232,00 € | ||
250mg | 453,00 € | ||
500mg | 645,00 € |
Información del producto
- 2,3-Dihydro-3[[[4-[methyl[2-(4-methyl-1-piperazinyl)acetyl]amino]phenylmethylene]-2-oxo-1H-indole-6-carboxylic acid methyl ester
Nintedanib is a medicinal inhibitor that targets cancer cells by inhibiting protein kinases. It has been shown to be effective against various types of tumors, including leukemia. Nintedanib exerts its anti-cancer effects by disrupting the cell cycle and inducing apoptosis in tumor cells. This drug has been tested on human cancer cell lines and has shown promising results in inhibiting tumor growth. Additionally, studies have shown that nintedanib can inhibit angiogenesis, which is the formation of new blood vessels that supply nutrients to tumors. This makes it a potential treatment for cancers that rely on angiogenesis for their growth.
Propiedades químicas
Consulta técnica sobre: 3D-KWB29426 Vargatef
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.